Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microarray Analysis of Infliximab in IMIDs
NCT00462072Phase 4Completed
- Sponsor
- University of Rochester
- Start
- Mar 2007
- Primary completion
- Jun 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of infliximab in rheumatoid arthritis (RA), psoriatic arthritis (PsA), psoriasis, Crohn's disease, sponsored by University of Rochester. Started Mar 2007; status: completed.
02
Drugs
infliximab
03
Conditions
rheumatoid arthritis (RA)psoriatic arthritis (PsA)psoriasisCrohn's disease
Beyond the preview
Go deeper on NCT00462072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00462072.